inFollow
inFollow

Beijing Longwood Valley Medical Technology Co., Ltd.
北京长木谷医疗科技股份有限公司

Manufacturer
Software/Algorithm

Beijing developer of ROPA, an NMPA-approved AI orthopedic surgical robot for hip and knee replacement.

Visit Website

Company Overview

Beijing Longwood Valley Medical Technology Co., Ltd., operating under the brand Changmugu, is a Chinese orthopedic AI and surgical robotics company founded on April 17, 2018 and led by CEO Dr. Zhang Yiling. The company is headquartered in the Beijing Economic-Technological Development Area in Tongzhou District, Beijing, with registered capital of RMB 30 million, and holds Class II and Class III medical device production and operation licenses. Changmugu has been recognized as a National High-tech Enterprise and as a national-level 'little giant' (specialized, refined, differentiated and innovative) enterprise for its work applying artificial intelligence to orthopedic surgery.

The company's core technology combines AI deep learning, 3D printing and surgical navigation to support pre-operative planning and intra-operative guidance for joint replacement surgery. Its AIJOINT AI surgical simulation and planning software, covering hip and knee applications marketed as AIHIP and AIKNEE, received what the company describes as China's first Class III innovative medical device certificate for an AI-plus-orthopedic-treatment product. In October 2024, Changmugu's ROPA orthopedic surgical robot received NMPA approval, which the company and Chinese media described as the world's first AI-plus-robot orthopedic surgical robot to reach the market, combining the AI planning software with a robotic arm for precision guidance during total hip and knee replacement procedures.

Changmugu has raised institutional financing to support its R&D and regulatory work, including an early Series A round of several tens of millions of RMB around 2020 and a Series B round of RMB 540 million completed around 2021, with investors reported to include CICC Capital, IDG Capital and CDH's VGC fund, and CEC Capital Group serving as exclusive financial advisor on the B round. The company has also established a strategic partnership with Johnson & Johnson Medical focused on orthopedic joint digitization and AI-assisted 3D precision diagnosis and treatment in China.

Through its combination of AI planning software and the NMPA-approved ROPA robotic platform, Changmugu positions itself as a domestic alternative to imported orthopedic surgical robots, targeting hospital joint replacement departments across China.

Capabilities & Activities

Primary type & automation activities this supplier delivers:

Applications & Industries

Product Categories

Products & Solutions

ROPA
  • Launch Year: 2024

NMPA-approved AI orthopedic surgical robot combining a robotic arm with AI planning for hip and knee replacement.

AIJOINT

AI surgical simulation and planning software for joint replacement, covering hip (AIHIP) and knee (AIKNEE) applications.

Partnership & Notable clients

Associating Events

Listed in RobotToday Supplier Discovery. Verified Profile

More related news

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
    Software, Compute and Interaction at WRC 2026 RobotToday  · Aug 31, 2026
  17. 17
  18. 18
  19. 19
  20. 20

Contact Beijing Longwood Valley Medical Technology Co., Ltd.

WEBSITE

https://changmugu.com/

HEADQUARTERS

Yard 3, Jinghai 5th Road, Building 19 (Floors 1-5, Unit 8-101)
Beijing , Beijing

China

Company Facts

Founded

2018

Primary Role

Manufacturer

Company Size

-

Primary Region

Asia-Pacific

Annual Sales

-

Funding Stage

Growth / Late-Stage VC

Funding Total

-

Certifications & Memberships

Keywords

© Copyright 2026 RobotToday. All rights reserved powered by RobotToday.com